UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 96

Sortiert nach

Comparison of Definitive Cervical Cancer Management With Chemotherapy and Radiation Between Two Centers With Variable Resources and Opportunities for Improved Treatment

JCO global oncology, 2020-10, Vol.6 (6), p.1510-1518

2020

Volltextzugriff (PDF)

Randomized Phase II Trial of Triapine-Cisplatin-Radiotherapy for Locally Advanced Stage Uterine Cervix or Vaginal Cancers

Frontiers in oncology, 2019-10, Vol.9, p.1067-1067

2019

Volltextzugriff (PDF)

Prognostic features of endometrial cancer metastasis to the central nervous system

PloS one, 2022-08, Vol.17 (8), p.e0268794-e0268794

2022

Volltextzugriff (PDF)

Phase 3, randomized, single-dose, open-label study to investigate the safety and efficacy of pafolacianine sodium injection (OTL38) for intraoperative imaging of folate receptor positive ovarian cancer

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.5503-5503

2021

Volltextzugriff (PDF)

BAD Phosphorylation Determines Ovarian Cancer Chemosensitivity and Patient Survival

Clinical cancer research, 2011-10, Vol.17 (19), p.6356-6366

2011

Volltextzugriff (PDF)

Phase I study of oral ridaforolimus in combination with paclitaxel and carboplatin in patients with solid tumor cancers

BMC cancer, 2017-06, Vol.17 (1), p.407-407, Article 407

2017

Volltextzugriff (PDF)

Ovarian microcystic stromal tumor: Radiologic-pathologic correlation

Gynecologic oncology reports, 2018-08, Vol.25, p.11-14

2018

Volltextzugriff (PDF)

Major vascular injury during gynecologic cancer surgery

Gynecologic oncology reports, 2021-08, Vol.37, p.100815, Article 100815

2021

Volltextzugriff (PDF)

Gene expression data reveal common pathways that characterize the unifocal nature of ovarian cancer

American journal of obstetrics and gynecology, 2013-12, Vol.209 (6), p.576.e1-576.e16

2013

Volltextzugriff (PDF)

Perifosine, an AKT inhibitor, modulates ovarian cancer cell line sensitivity to cisplatin-induced growth arrest

Gynecologic oncology, 2013-10, Vol.131 (1), p.207-212

2013

Volltextzugriff (PDF)

Targeted therapies in gynecologic cancers

Current cancer drug targets, 2006-06, Vol.6 (4), p.333

2006

Volltextzugriff (PDF)

The O-glycan pathway is associated with in vitro sensitivity to gemcitabine and overall survival from ovarian cancer

International journal of oncology, 2012-07, Vol.41 (1), p.179-188

2012

Volltextzugriff (PDF)

Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer

The New England journal of medicine, 2021-11, Vol.385 (20), p.1856-1867

2021

Volltextzugriff (PDF)

Barriers to clinical trial enrollment among gynecologic oncology patients at a national cancer institute-designated comprehensive cancer center (2196)

Gynecologic oncology, 2023-09, Vol.176, p.S254-S254

2023

Volltextzugriff (PDF)

Specimen extraction techniques utilized in minimally invasive surgery for women with uterine cancer and an enlarged Uterus: A quality assurance study (1108)

Gynecologic oncology, 2023-09, Vol.176, p.S82-S83

2023

Volltextzugriff (PDF)

Barriers to clinical trial enrollment among gynecologic oncology patients at a National Cancer Institute Comprehensive Cancer Center

Gynecologic oncology, 2021-08, Vol.162, p.S98-S98

2021

Volltextzugriff (PDF)

A Phase III Study of Pafolacianine Injection (OTL38) for Intraoperative Imaging of Folate Receptor-Positive Ovarian Cancer (Study 006)

Journal of clinical oncology, 2023-01, Vol.41 (2), p.276-284

2023

Volltextzugriff (PDF)

Impact of age, comorbidity, and treatment characteristics on survival in older women with advanced high grade epithelial ovarian cancer

Gynecologic oncology, 2021-06, Vol.161 (3), p.693-699

2021

Volltextzugriff (PDF)

P12 Feasibility study for electroacupuncture for chemotherapy-induced peripheral neuropathy using a point-of-care nerve conduction device (DPNCheck) and the Rydel-Seiffer tuning fork

Gynecologic oncology, 2023-07, Vol.173, p.S14-S15

2023

Volltextzugriff (PDF)

GOG 3026 A phase II trial of letrozole + ribociclib in women with recurrent low-grade serous carcinoma of the ovary, fallopian tube or peritoneum: A GOG foundation study (001)

Gynecologic oncology, 2023-09, Vol.176, p.S2-S2

2023

Volltextzugriff (PDF)

Using the Radiosensitivity Index (RSI) to Predict Pelvic Failure in Endometrial Cancer Treated With Adjuvant Radiation Therapy

International journal of radiation oncology, biology, physics, 2020-03, Vol.106 (3), p.496-502

2020

Volltextzugriff (PDF)

Incorporation of triapine (T) with cisplatin chemoradiation (CRT) for locally advanced cervical and vaginal cancer: Results from NRG-GY006, a phase III randomized trial

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.5502-5502

2023

Volltextzugriff (PDF)

1 – 25 von 96

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(93)
Mit Volltextzugriff
(82)

Publikationsform

Artikel
(94)
Berichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(45)
Life Sciences & Biomedicine
(41)
Humans
(38)
Female
(36)
Oncology
(36)
Middle Aged
(16)
Obstetrics & Gynecology
(16)
Ovarian Cancer
(14)
Adult
(12)
Aged
(11)
Ovarian Neoplasms - Drug Therapy
(8)
Retrospective Studies
(8)
Aged, 80 And Over
(7)
Cancer Therapies
(7)
Gene Expression
(7)
Ovarian Neoplasms - Genetics
(7)
Signal Transduction
(7)
Antineoplastic Agents - Therapeutic Use
(6)
Cancer
(6)
Cell Line, Tumor
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Comparison of Definitive Cervical Cancer Management With Chemotherapy and Radiation Between Two Centers With Variable Resources and Opportunities for Improved Treatment

Randomized Phase II Trial of Triapine-Cisplatin-Radiotherapy for Locally Advanced Stage Uterine Cervix or Vaginal Cancers

Prognostic features of endometrial cancer metastasis to the central nervous system

Phase 3, randomized, single-dose, open-label study to investigate the safety and efficacy of pafolacianine sodium injection (OTL38) for intraoperative imaging of folate receptor positive ovarian cancer

BAD Phosphorylation Determines Ovarian Cancer Chemosensitivity and Patient Survival

Phase I study of oral ridaforolimus in combination with paclitaxel and carboplatin in patients with solid tumor cancers

Relationships among Inflammatory Biomarkers and Objectively Assessed Physical Activity and Sleep during and after Chemotherapy for Gynecologic Malignancies

Ovarian microcystic stromal tumor: Radiologic-pathologic correlation

Major vascular injury during gynecologic cancer surgery

Gene expression data reveal common pathways that characterize the unifocal nature of ovarian cancer

Perifosine, an AKT inhibitor, modulates ovarian cancer cell line sensitivity to cisplatin-induced growth arrest

Targeted therapies in gynecologic cancers

The O-glycan pathway is associated with in vitro sensitivity to gemcitabine and overall survival from ovarian cancer

Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer

Barriers to clinical trial enrollment among gynecologic oncology patients at a national cancer institute-designated comprehensive cancer center (2196)

Specimen extraction techniques utilized in minimally invasive surgery for women with uterine cancer and an enlarged Uterus: A quality assurance study (1108)

Barriers to clinical trial enrollment among gynecologic oncology patients at a National Cancer Institute Comprehensive Cancer Center

A Phase III Study of Pafolacianine Injection (OTL38) for Intraoperative Imaging of Folate Receptor-Positive Ovarian Cancer (Study 006)

Impact of age, comorbidity, and treatment characteristics on survival in older women with advanced high grade epithelial ovarian cancer

P12 Feasibility study for electroacupuncture for chemotherapy-induced peripheral neuropathy using a point-of-care nerve conduction device (DPNCheck) and the Rydel-Seiffer tuning fork

Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial

GOG 3026 A phase II trial of letrozole + ribociclib in women with recurrent low-grade serous carcinoma of the ovary, fallopian tube or peritoneum: A GOG foundation study (001)

Using the Radiosensitivity Index (RSI) to Predict Pelvic Failure in Endometrial Cancer Treated With Adjuvant Radiation Therapy

Oral Selinexor as Maintenance Therapy After First-Line Chemotherapy for Advanced or Recurrent Endometrial Cancer

Incorporation of triapine (T) with cisplatin chemoradiation (CRT) for locally advanced cervical and vaginal cancer: Results from NRG-GY006, a phase III randomized trial

Suchergebnisse filtern